Nike (NKE) Q1 Earnings: FY27 Guidance Cut & 13-Year Low Skip to Main Content

Nike Stock Sinks to 13-Year Low on Gutted FY27 Guidance & Q1 Revenue Miss

|
Share on social media

Nike (NKE) stock reported Q1 FY2027 earnings after the close on October 1, 2026, posting EPS of $0.48 (beating the $0.44 estimate) but missing on revenue at $11.21B versus the $11.33B consensus. The headline beat was overshadowed by a dramatically lowered full-year EPS outlook of $1.15-$1.35 versus the $1.69 analyst estimate, sending shares to their lowest level since 2013. The company simultaneously announced “PACE,” a sweeping operational restructuring expected to deliver $2.5B in cumulative savings through FY2031, but investors focused on the severity of near-term headwinds.

NIKE STOCK PAIN CONTINUES

Key Drivers of the NKE Stock Move

  • Main Catalyst: FY2027 EPS guidance of $1.15-$1.35 came in roughly 25% below Wall Street’s $1.69 estimate, with management explicitly warning that revenue declines in Nike Sportswear, Jordan Brand, and Greater China will persist “through the remainder of FY27 and into FY28.”
  • Bull Case: Nike’s performance sports portfolio (running, football, basketball, training) grew high single digits in Q1, gross margin expanded 60 bps to 42.8%, and the PACE program is projected to unlock $2.5B in savings. CEO Elliott Hill framed turnaround signals as real and the Caitlin Clark basketball launch was called the largest women’s signature shoe launch in company history.
  • Bear Case: Greater China revenue plunged 26% in Q1 and management guided it to worsen through FY27. Nike Sportswear, which represents just under half of quarterly revenue, was down low double digits. The dividend payout ratio on midpoint FY27 guidance exceeds 100%, raising sustainability questions despite management’s strong assurances.
NKE stock graph

Nike is a company in a multi-year reset, navigating simultaneous challenges in its three largest problem areas. The Jordan Brand scarcity restoration, China digital cleanup, and Sportswear segmentation strategy are all structurally sound approaches, but management has been clear that “pain before gain” extends well into FY28. The stock hitting 13-year lows signals the market is pricing in an extended recovery timeline, not just a one-quarter stumble.

NKE Earnings Call Transcript Summary

CEO Elliott Hill and new CFO Dave Denton struck a tone of disciplined urgency on the Q1 FY2027 call, acknowledging that while the sport performance offense is working, it is not yet large enough to offset the drags from Sportswear, Jordan, and Greater China. The PACE restructuring program was positioned as the operating model overhaul needed to scale what is working and cut what is not.

  • Nike’s performance portfolio (running, football, basketball, training, tennis, golf) grew high single digits in Q1, with running nearly tripling its share of the max cushioning category over the past year on the back of the Vomero franchise.
  • Greater China declined 26% and is guided to worsen for the balance of FY27 as Nike deliberately eliminates unprofitable digital distribution and anchors around fewer, higher-quality flagship storefronts on Tmall, JD, and Douyin.
  • The PACE program targets approximately $2.5B in cumulative savings through FY2031, with the majority of savings expected to be realized in FY29 and FY30, and implementation costs estimated at approximately $1B over the program’s life.

NKE Smart Money Activity

Insider activity has been dominated by scheduled compensation awards. In September 2026, CEO Elliott Hill received an equity award of 108,400 shares plus 395,570 stock appreciation rights, while new CFO Dave Denton received 71,234 shares and 259,946 SARs as part of his onboarding package. Several officers, including COO Venkatesh Alagirisamy and CLO Robert Leinwand, made modest open-market disposals in August and September (ranging from $21K to $138K), consistent with routine tax-related selling on vested awards rather than discretionary exits. On the government side, Democratic Rep. Ro Khanna purchased NKE twice in July (at a loss), then sold in August and again in late August, booking losses of roughly 15-21% on each round trip. Rep. Kevin Hern (R) and Rep. Gilbert Cisneros (D) also sold in August at losses. No member of Congress appears to have made a profitable directional bet on NKE in this period.

NKE smart money table

NKE Unusual Options

Options flow in the week ahead of and on earnings day was notably mixed but leaned bearish in premium size. The largest single trade was a $522K sweep on June 2028 $27.50 puts (bearish, at ask) on September 29, suggesting at least one large participant was positioning for a sustained multi-year decline below $27.50. A recurring $162-163K bearish sweep appeared on December 2026 $90 puts across multiple sessions, widely flagged as a protective or speculative position. On the bullish side, a $930K block in November 2026 $37.50 calls printed on October 1 (at ask), one of the largest single premiums in the dataset, and $78K in January 2029 $35 calls also traded bullishly above ask. The flow picture is conflicted: short-term put sweeps dominate by frequency, while isolated large call blocks reflect bottom-fishing by some participants ahead of the print.

NKE unusual options chart

NKE Analyst Focus

  • Notable Downgrades: Bank of America downgraded to Underperform with a $30 target on Sep 25 (from $47). JP Morgan downgraded to Sell on Aug 4 (PT: $40). Truist downgraded to Hold on Aug 26 (PT: $42). Baird downgraded to Hold on Sep 14 (PT: $44, from $70). BMO initiated at Sell with a $30 target on Sep 9.
  • Notable Buys/Maintains: BTIG reiterated Buy with a $55 target (Sep 23). Barclays maintained Overweight at $48 (Sep 23). Oppenheimer maintained Outperform at $52 (Sep 23).
  • Median Price Target: Based on the most recent targets available, the range spans $30 (BofA, BMO) to $55 (BTIG), with the median across active ratings sitting approximately in the $38-$40 range, implying limited near-term upside consensus at current prices.
NKE analyst table

NKE Seasonality

Based on data since January 2014 (13 samples per month). NKE has historically shown its strongest seasonal tailwind in November, which has been positive in 92% of years with an average gain of +5.2%, the clear standout month. July (69% positive, +2.6%) and June (62% positive, +2.0%) also tend to favor the bulls. In contrast, March is the single worst month historically, positive only 15% of the time with an average decline of -4.6%. April (-2.1%, 31% positive) and January (-0.7%, 38% positive) are also seasonally weak. With NKE entering October (46% positive, +0.4% average), seasonal tailwinds are neutral at best for the near term, but if the stock stabilizes into November, history suggests that month is where NKE tends to catch a bid.

NKE seasonality chart

NKE Relative Performance

NKE’s TechRank within its own sector (Consumer Discretionary) has been persistently weak, hovering in the 17-32 percentile range from July through September 2026. That means NKE has been outperforming fewer than one-third of its sector peers on a technical basis for the entire three-month stretch. There was a modest uptick to the ~30-31 percentile range in the final days of September heading into earnings, but at roughly the 20th percentile for most of the period, NKE is a clear sector laggard. For context, a reading above 50 would indicate the stock is outperforming more than half of its peers; NKE has not come close to that threshold during this window.

Stay up-to-date: Subscribe to posts like this!

Receive automated updates from the Posts category
This site is protected by reCAPTCHA and the Google Privacy Policy and Google Terms of Service apply. Don't worry, we hate spam, too! See TrendSpider Privacy Policy for details.

Latest posts

|

Jensen Huang Resigns as NVIDIA CEO: What it Means for NVDA Stock

After 33 years at the helm of the company he co-founded, Jensen Huang resigned as President, CEO, and board member of NVDA effective immediately on November 12, 2026. The departure was triggered by a deepening scandal involving alleged ties to a suspected Chinese intelligence asset, a second workplace affair, and a cascade of regulatory and […]
|

CoreWeave Stock Q3 Earnings: $3.7B Revenue Beat & 2026 Guide Raise

CoreWeave (CRWV) stock delivered a commanding Q3 2026 earnings beat on November 10, posting revenue of $3.7 billion against a consensus estimate of $3.5 billion and an adjusted EPS loss of $0.95 versus the expected $1.53 — a 38% EPS beat. The company simultaneously raised its full-year 2026 revenue guidance to $13.0–$13.3 billion, sparking an […]
|

Hims & Hers Stock Slides as Q3 EPS Miss & Weak Guide Shadow 49% Sales

Hims & Hers Health (HIMS) stock delivered another quarter of robust top-line expansion in Q3 2026, with revenue surging 48.7% year-over-year to $890.4M. However, an adjusted EPS miss and a materially below-consensus Q4 outlook sent shares sharply lower after the report, reflecting growing investor concern about profitability and the post-GLP-1 compounding transition. Key Takeaways: Beat […]
|

Rocket Lab Corporation Stock Drops as Q3 EPS Miss & Neutron Slip Outshine 73% Sales

Rocket Lab Corporation (RKLB) stock reported its strongest quarter on record in Q3 2026, with revenue surging 72.7% year-over-year to $267.8M, beating the $257.0M consensus by 4.2%. However, an adjusted EPS miss of -$0.08 versus the -$0.07 estimate, compounding concerns around the Neutron rocket’s delayed debut, sent shares tumbling more than 8% in after-hours trading […]